🇺🇸 FDA
Patent

US 7585868

Substituted pyrazolo[3,4-D]pyrimidines as kinase antagonists

granted A61PA61P11/00A61P11/06

Quick answer

US patent 7585868 (Substituted pyrazolo[3,4-D]pyrimidines as kinase antagonists) held by The Regents of the University of California expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P11/00, A61P11/06, A61P19/02, A61P19/08